Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 2,993–3,000 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Novartis AG SB17 ustekinumab - (biosimilar) Autoimmune disorders including Crohn's disease, plaque psoriasis, psoriatic arthritis, and ulcerative colitis Phase 3 Subcutaneous Immunology: Anti-TNF
Novartis AG Leqvio (ORION-8) Atherosclerotic cardiovascular disease (ASCVD), increased risk of ASCVD or heterozygous familial hypercholesterolemia (HeFH) Phase 3 Data Released Subcutaneous Cardiology
Novartis AG Kesimpta (ofatumumab) - (ALITHIOS) Relapsing Multiple Sclerosis Phase 3 Data Released Subcutaneous Neurology
Novartis AG Iptacopan - (APPOINT-PNH) Paroxysmal nocturnal hemoglobinuria (PNH) Phase 3 Data Released Oral Hematology
Novartis AG Coartem (artemether-lumefantrine) - (CALINA) Malaria in babies <5 kg Phase 2/3 Data Released Oral Antimalarial
Novartis AG CNP520 Alzheimer’s Disease Phase 2/3 Trial Discontinued oral Neurology
Novartis AG TOUR006 - (spiriTED) Thyroid Eye Disease (TED) Phase 2b Ongoing Intravenous Opthalmic
Novartis AG XXB750 Hypertension Phase 2b Trial Discontinued Intravenous Cardiology
1…373374375376377…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.